A Phase I/II Study to Evaluate the Safety and Efficacy of the Allogeneic Injection of Expanded Adipose-derived Stem Cells to Patients With Knee Osteoarthritis
Latest Information Update: 29 Sep 2023
At a glance
- Drugs Adipose-derived stem cells-UnicoCell (Primary) ; Hyaluronic acid
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors UnicoCell Biomed
- 14 Jul 2021 Status changed from active, no longer recruiting to completed.
- 23 Sep 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 23 Sep 2019 Status changed from recruiting to active, no longer recruiting.